Geoff Meacham

Stock Analyst at Citigroup

(4.26)
# 396
Out of 5,042 analysts
273
Total ratings
60.69%
Success rate
11.8%
Average return

Stocks Rated by Geoff Meacham

Moderna
Oct 23, 2025
Maintains: Neutral
Price Target: $30$28
Current: $26.74
Upside: +4.71%
Protagonist Therapeutics
Oct 17, 2025
Maintains: Buy
Price Target: $72$96
Current: $74.86
Upside: +28.24%
NewAmsterdam Pharma Company
Oct 17, 2025
Maintains: Buy
Price Target: $42$50
Current: $35.72
Upside: +39.98%
Kymera Therapeutics
Oct 17, 2025
Maintains: Buy
Price Target: $60$80
Current: $58.56
Upside: +36.61%
Kiniksa Pharmaceuticals International,
Oct 17, 2025
Maintains: Buy
Price Target: $45$50
Current: $38.93
Upside: +28.44%
Amylyx Pharmaceuticals
Oct 17, 2025
Maintains: Buy
Price Target: $12$20
Current: $14.17
Upside: +41.14%
CRISPR Therapeutics AG
Oct 17, 2025
Maintains: Buy
Price Target: $78$93
Current: $67.61
Upside: +37.55%
Regeneron Pharmaceuticals
Oct 13, 2025
Maintains: Buy
Price Target: $650$660
Current: $577.95
Upside: +14.20%
Merck & Co.
Oct 13, 2025
Reinstates: Neutral
Price Target: $84$95
Current: $87.49
Upside: +8.58%
Gilead Sciences
Oct 8, 2025
Maintains: Buy
Price Target: $125$135
Current: $120.94
Upside: +11.63%
Maintains: Neutral
Price Target: $220$251
Current: $227.99
Upside: +10.09%
Maintains: Buy
Price Target: $550$575
Current: $421.39
Upside: +36.45%
Maintains: Buy
Price Target: $56$65
Current: $49.15
Upside: +32.25%
Upgrades: Buy
Price Target: $12$14
Current: $5.98
Upside: +134.11%
Maintains: Buy
Price Target: $10$9
Current: $2.21
Upside: +307.24%
Maintains: Neutral
Price Target: $305$310
Current: $291.76
Upside: +6.25%
Maintains: Neutral
Price Target: $125$135
Current: $149.89
Upside: -9.93%
Maintains: Neutral
Price Target: $40$50
Current: $66.40
Upside: -24.70%
Maintains: Buy
Price Target: $40$42
Current: $37.26
Upside: +12.72%
Maintains: Buy
Price Target: $50$54
Current: $54.26
Upside: -0.48%
Initiates: Buy
Price Target: $110
Current: $84.68
Upside: +29.90%
Initiates: Sell
Price Target: $6
Current: $8.52
Upside: -29.58%
Maintains: Buy
Price Target: $145$140
Current: $105.66
Upside: +32.50%
Downgrades: Underperform
Price Target: $7$1
Current: $2.63
Upside: -61.98%
Initiates: Buy
Price Target: $95
Current: $53.32
Upside: +78.17%
Initiates: Buy
Price Target: $25
Current: $14.79
Upside: +69.03%
Maintains: Buy
Price Target: $99$103
Current: $54.48
Upside: +89.06%
Downgrades: Underperform
Price Target: $112$4
Current: $2.33
Upside: +71.67%
Maintains: Buy
Price Target: $1,150$1,100
Current: $825.45
Upside: +33.26%
Downgrades: Underperform
Price Target: $120$20
Current: $17.64
Upside: +13.38%
Upgrades: Buy
Price Target: $22$31
Current: $14.23
Upside: +117.85%
Maintains: Neutral
Price Target: $180$170
Current: $190.40
Upside: -10.71%
Maintains: Buy
Price Target: $24$48
Current: $24.90
Upside: +92.77%
Downgrades: Neutral
Price Target: $68$60
Current: $43.83
Upside: +36.89%
Maintains: Underperform
Price Target: $10$8
Current: $5.36
Upside: +49.25%
Maintains: Buy
Price Target: $19$17
Current: $1.82
Upside: +834.07%
Maintains: Neutral
Price Target: $50$45
Current: $24.76
Upside: +81.74%
Downgrades: Underperform
Price Target: $24
Current: $2.33
Upside: +930.04%
Downgrades: Neutral
Price Target: $12$4
Current: $7.55
Upside: -47.02%
Initiates: Buy
Price Target: $28
Current: $2.38
Upside: +1,076.47%
Initiates: Buy
Price Target: $34
Current: $0.58
Upside: +5,789.49%
Downgrades: Neutral
Price Target: $35
Current: $2.71
Upside: +1,191.51%
Initiates: Buy
Price Target: $525
Current: $8.43
Upside: +6,127.76%
Initiates: Buy
Price Target: $42
Current: $1.56
Upside: +2,592.31%
Reinstates: Buy
Price Target: $20
Current: $8.72
Upside: +129.36%
Reinstates: Buy
Price Target: $20
Current: $0.63
Upside: +3,058.06%
Reinstates: Underperform
Price Target: $9
Current: $5.23
Upside: +72.08%
Reinstates: Buy
Price Target: $60
Current: $13.03
Upside: +360.48%
Initiates: Underperform
Price Target: $7
Current: $4.29
Upside: +63.36%
Maintains: Equal-Weight
Price Target: $15$23
Current: $17.74
Upside: +29.65%
Downgrades: Equal-Weight
Price Target: $90$82
Current: $91.28
Upside: -10.17%
Maintains: Underweight
Price Target: $100$95
Current: $418.58
Upside: -77.30%
Downgrades: Equal-Weight
Price Target: $300$80
Current: $15.41
Upside: +419.14%
Maintains: Overweight
Price Target: $100$135
Current: $144.00
Upside: -6.25%
Downgrades: Underweight
Price Target: n/a
Current: $9.82
Upside: -
Maintains: Equal-Weight
Price Target: $16$20
Current: $1.66
Upside: +1,104.82%
Downgrades: Equal-Weight
Price Target: n/a
Current: $16.60
Upside: -
Maintains: Overweight
Price Target: $127$158
Current: $463.43
Upside: -65.91%